Literature DB >> 10091391

Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield.

M A Díaz1, F Garcia-Sanchez, R Lillo, M G Vicent, J L Vicario, L Madero.   

Abstract

BACKGROUND AND
OBJECTIVE: In children it is very important to optimize PBPC harvesting and to reduce the number of leukaphereses per patient. The value of pre-apheresis peripheral blood CD34+ cell concentration as a predictor of PBPC yield was studied in 23 pediatric patients with hematologic and non-hematologic malignancies in order to optimize duration of PBPC collection. DESIGN AND METHODS: The patients underwent 25 stem-cell mobilization episodes with G-CSF alone and 40 large-volume leukapheresis procedures. Peripheral blood and harvested CD34+ cell concentrations were analyzed by means of flow cytometry.
RESULTS: Using linear regression analysis, a highly significant correlation was found between the peripheral blood CD34+ cell count and the CD34+ cells/kg patient body weight collected on the apheresis day (r = 0.826, p = 0.0001). The results indicate that at least 1 x 10(6)/kg CD34+ cells can be harvested during one leukapheresis procedure in all patients if the pre-apheresis blood CD34+ cell count is > or = 30/microL and a CD34+ cell target of > or = 5 x 10(6)/kg is achieved in at least 80% of patients if this value is > or = 50 CD34+ cells/microL processing a median blood volume of 438.7 mL/kg (range, 207-560) over a median time of 232.5 minutes (range, 182-376). INTERPRETATION AND
CONCLUSIONS: Our results suggest that the number of CD34+ cells harvested in a single large-volume leukapheresis can be predicted from the measurement of peripheral blood CD34+ cell concentration on the collection day.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091391

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  3 in total

Review 1.  Anticoagulation techniques in apheresis: from heparin to citrate and beyond.

Authors:  Grace Lee; Gowthami M Arepally
Journal:  J Clin Apher       Date:  2012-04-24       Impact factor: 2.821

2.  Large volume leukapheresis is efficient and safe even in small children up to 15 kg body weight.

Authors:  Ines Bojanic; Sanja Mazic; Ljubica Rajic; Gordana Jakovljevic; Jasminka Stepan; Branka Golubic Cepulic
Journal:  Blood Transfus       Date:  2016-01-13       Impact factor: 3.443

3.  A high-throughput microfluidic device based on controlled incremental filtration to enable centrifugation-free, low extracorporeal volume leukapheresis.

Authors:  Dalia L Lezzar; Fong W Lam; Ravin Huerta; Anton Mukhamedshin; Madeleine Lu; Sergey S Shevkoplyas
Journal:  Sci Rep       Date:  2022-08-13       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.